StockSelector.com
  Research, Select, & Monitor Monday, October 21, 2019 9:04:16 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Sangamo Therapeutics, Inc.$8.31($.32)(3.71%)

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Sangamo Therapeutics, Inc. has an overall rank of 1740 out of 7004 stocks based on 9 positive rankings and 7 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $16.00 for Sangamo Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Sangamo Therapeutics is ranked 114.
Highest Cash Growth
Sangamo Therapeutics rank is 115
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Sangamo Therapeutics is ranked 257.
Historic Revenue Growth
Sangamo Therapeutics rank is 435
Estimated Revenue Growth
Sangamo Therapeutics rank is 540
Low vPut/Call
Sangamo Therapeutics has a low Put/Call ratio of 0.28 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Sangamo Therapeutics is ranked 545.
Low Put/Call
Sangamo Therapeutics has a low Put/Call ratio of 0.30 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Sangamo Therapeutics is ranked 701.
Up EPS Surprise
Sangamo Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Debt-to-Equity
Sangamo Therapeutics rank is 1305
Negative Rankings
Price-to-Sales
Sangamo Therapeutics rank is 408
Negative Net Margin
Sangamo Therapeutics rank is 447
10 Day Loss
Sangamo Therapeutics rank is 1013
Negative ROE
Sangamo Therapeutics rank is 1020
Negative ROA
Sangamo Therapeutics rank is 1147
90 Day Loss
Sangamo Therapeutics rank is 1265
Price-to-Book
Sangamo Therapeutics rank is 1857







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.